Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 0 | |
Outperform | 2 | |
Hold | 0 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 2 analysts offering 12 month price targets for Vivos Therapeutics Inc have a median target of 7.42, with a high estimate of 8.25 and a low estimate of 6.60. The median estimate represents a 140.13% increase from the last price of 3.09.
High | 167.0% | 8.25 |
Med | 140.1% | 7.42 |
Low | 113.6% | 6.60 |
Earnings history & estimates in USD
The next earnings announcement is expected on Nov 12, 2024.
Average growth rate | +21.37% |
Average growth rate | +26.75% |
More ▼
Revenue history & estimates in USD
Average growth rate | +4.87% |
Average growth rate | +3.42% |
More ▼